...
首页> 外文期刊>Journal of Clinical Microbiology >Activity of Contemporary Antifungal Agents, Including the Novel Echinocandin Anidulafungin, Tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: Report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007)
【24h】

Activity of Contemporary Antifungal Agents, Including the Novel Echinocandin Anidulafungin, Tested against Candida spp., Cryptococcus spp., and Aspergillus spp.: Report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007)

机译:经过抗念珠菌,隐球菌和曲霉菌测试的当代抗真菌剂,包括新型棘皮and苷安地芬净的活性:SENTRY抗菌素监测计划的报告(2006年至2007年)

获取原文
           

摘要

Results from the SENTRY international fungal surveillance program for 2006 to 2007 are presented. A total of 1,448 Candida sp., 49 Aspergillus fumigatus, and 33 Cryptococcus neoformans isolates were obtained from infected sterile-site sources in patients on five continents. Reference susceptibility was determined for anidulafungin, caspofungin, 5-flucytosine, fluconazole, itraconazole, posaconazole, voriconazole, and amphotericin B by CLSI methods.
机译:介绍了SENTRY国际真菌监测计划2006至2007年的结果。从五个地点的患者中,从感染的无菌位点来源获得了总计1,448个 Candida 菌,49个烟曲霉和33个新隐球菌分离株。大洲。通过CLSI方法确定了对阿尼芬净,卡泊芬净,5-氟胞嘧啶,氟康唑,伊曲康唑,泊沙康唑,伏立康唑和两性霉素B的参考药敏性。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号